Skip to content
PaperFren

Screening and breast cancer equity in NZ

Open paper intelligence

Screen-detected cancers were less common in Māori women, and crude survival was worse, but survival gaps narrowed among screen-detected cases.

Source

Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study

Seneviratne S, Campbell I, Scott N, et al. · BMC public health · 2015

doi.org/10.1186/s12889-015-1383-4Read the full paper ↗33 citationscc by

Study at a glance

Design
Cohort — New Zealand screening-age women with first primary breast cancer; screen-detected vs symptomatic
N
N=1846 · 1,548 invasive and 298 in-situ; 1,064 (57.6%) screen-detected
Population
Screening-age women in New Zealand with newly diagnosed first primary breast cancer
Outcome
Screen detection rates and cancer-specific survival by ethnicity

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Screening and breast cancer equity in NZ

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

1846 screening-age women were included.

This study included a total of 1846 screening age women (1548 invasive and 298 in-situ) with newly diagnosed first primary breast cancer over the study period.

1064 cancers (57.6%) were screen detected.

Of these women 1064 (57.6%) were screen detected and 782 (42.4%) were symptomatic.
Read passages in the original paper

What they did

A New Zealand cohort of screening-age women with first primary breast cancer compared screen-detected versus symptomatic cancers by ethnicity and deprivation, examining stage and cancer-specific survival.

What they found

Among 1846 women, NZ European cancers were more often screen-detected than Māori cancers (62.7% vs 49.2%). Māori women had worse crude five- and ten-year survival overall, but among screen-detected cancers survival was similar or numerically better for Māori.

The limits

What it doesn't show

Observational screening associations cannot fully separate selection effects from screening benefit. Residual confounding and regional coverage variation remain.

Key terms

Screen-detected cancer
Cancer found through organised or opportunistic mammography rather than symptoms.
Interval cancer
Cancer diagnosed between screening rounds after a prior negative screen.
BreastScreen Aotearoa
New Zealand’s national mammographic screening programme.
Deprivation quintile
Socioeconomic ranking used to compare outcomes by area disadvantage.
Cancer-specific survival
Survival treating death from breast cancer as the event.
Stage at diagnosis
How advanced the cancer is when first found.

Flashcards

1 / 10

0 of 10 answers reviewed

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 6

Māori screen-detection vs NZ European was roughly:

Common questions

How many women were included?

1846 screening-age women with first primary breast cancer.

Screen detection in Māori vs European?

49.2% vs 62.7%.

Did screen-detected survival still favour Europeans?

No significant disadvantage for Māori among screen-detected cancers.

Overall crude survival?

Lower for Māori at five and ten years.

More on Health equity